Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Pozycja w akcjach #28845
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Cena akcji
$1.89
Ostatnia synchronizacja: 2022-12-16
Kapitalizacja rynkowa
$24.38M
Zmiana (1 dzień)
8.62%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Yumanity Therapeutics, Inc. (YMTX)

Kategoria

Wskaźnik P/S dla Yumanity Therapeutics, Inc. (YMTX)
Wskaźnik P/S na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji Yumanity Therapeutics, Inc., obecny wskaźnik P/S (TTM) wynosi 0. Na koniec 2026 wynosił 0.
Historia wskaźnika P/S dla Yumanity Therapeutics, Inc. od 2026 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
Za mało danych dla podanych dat.
Wskaźnik P/S dla podobnych firm lub konkurentów
Firma Wskaźnik P/S Różnica wskaźnika P/S Kraj
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH